In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication…
Consumers should sweat these claims.
Tackling gender bias in search.
TINA.org takes a closer look at company’s claims of ‘guaranteed income.’
A-listers face lawsuits over promotions of risky and unregulated investments.
Complaints against additional distributors who hosted COVID webinars may be forthcoming.